​

Funding Round

Series B - Nora Therapeutics

Series B - Nora Therapeutics

Investment Firm

Overview

Nora Therapeutics is a specialty biopharmaceutical company developing therapeutics to address clinical unmet needs in reproductive medicine.

Announced Date

Apr 17, 2014

Funding Type

Series B

Highlights

Location

United States, North America

Social

N/A

Investor Lead

Novo Holdings

Novo Holdings

Novo Holdings is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and secondary_market and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorBurrill & Company
Participant InvestorRho Ventures
Participant InvestorNovo Holdings
Participant InvestorProspect Venture Partners
Participant InvestorVivo Capital

Round Details and Background

Nora Therapeutics raised $18000000 on 2014-04-17 in Series B

Nora Therapeutics is a specialty biopharmaceutical company developing therapeutics to address clinical unmet needs in reproductive medicine.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 13, 2009
Seed Round - Nora Therapeutics
-1.0M
Sep 23, 2010
Series A - Nora Therapeutics
-14.9M
Apr 17, 2014
Series B - Nora Therapeutics
5-18.0M
Jun 02, 2010
Seed Round - Nora Therapeutics
-2.9M

Recent Activity

There is no recent news or activity for this profile.